269 filings
Page 8 of 14
8-K
5rxct
8 May 17
TherapeuticsMD Receives Complete Response Letter from FDA for TX-004HR New Drug Application
12:00am
8-K
b6o3xm77ry
2 May 17
TherapeuticsMD Announces First Quarter 2017 Financial Results
12:00am
8-K
3oj03d41t2xsj n51
10 Apr 17
TherapeuticsMD Provides TX-004HR Regulatory Update
12:00am
8-K
0de2t mtzdm2
1 Mar 17
Regulation FD Disclosure
12:00am
8-K
dqr74u
23 Feb 17
TherapeuticsMD Announces Fourth Quarter and Full-Year 2016 Financial Results
12:00am
8-K
bsgu3e3krfldlaslxayl
9 Jan 17
Regulation FD Disclosure
12:00am
8-K
1vb9h
8 Dec 16
1 TX - 001HR Supplemental Replenish Trial Design And Topline Phase 3 Results December 2016
12:00am
8-K
lt8i t0ikllq
5 Dec 16
Regulation FD Disclosure
12:00am
8-K
lw4ale6 b4utezbau2n
3 Nov 16
TherapeuticsMD Announces Third Quarter 2016 Financial Results
12:00am
8-K
f0j 6diaux8j
26 Sep 16
Regulation FD Disclosure
12:00am
8-K
4acnqsu32lvu0apnlf
19 Sep 16
Results of Operations and Financial Condition
12:00am
8-K
xhayt6r7hvue
22 Aug 16
Regulation FD Disclosure
12:00am
8-K
clekxz2pg
4 Aug 16
TherapeuticsMD Announces Second Quarter 2016 Financial Results
12:00am
8-K
f0fl 7bblb40dm
7 Jul 16
Regulation FD Disclosure
12:00am
8-K
31bugle
29 Jun 16
TherapeuticsMD Announces Filing Timeline for Yuvvexy (TX-004HR) New Drug Application
12:00am
8-K
dflz0ni9
20 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
b38ra38vvwuxg5
4 May 16
Regulation FD Disclosure
12:00am
8-K
i7amr gp3ypumwqs
3 May 16
TherapeuticsMD Announces First Quarter 2016 Financial Results
12:00am
8-K
8kfibaa
7 Mar 16
Regulation FD Disclosure
12:00am
8-K
3ol49idc27hsxrea
25 Feb 16
TherapeuticsMD Announces Fourth Quarter and Full Year 2015 Financial Results
12:00am